Michael S. Perry, Chief Executive Officer at Avita Therapeutics, Inc. (RCEL), sold 86,722 shares at $27.23 ($2.4M) on 2020-09-15, disclosed to the SEC on 2020-09-16.
Open-market sale of $2.4M RCEL by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.99 | 15,092 | $407K | 17.3% |
| 2 | $26.99 | 15,092 | $407K | 17.3% |
| 3 | $27.23 | 23,769 | $647K | 27.5% |
| 4 | $27.23 | 23,769 | $647K | 27.5% |
| 5 | $27.41 | 9,000 | $247K | 10.5% |
| Total | $27.17 avg | 86,722 |
| $2.4M |
| 100% |
| Filing → |
| RCEL | SELL | 2022-11-22 | $1.1M | — | Filing → |
| RCEL | SELL | 2022-02-25 | $189K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $460K | — | Filing → |